Paris, January 8, 2019 – 5.45 pm

Eurobio Scientific (FR0013240934, ALERS, eligible PEA-PME), leading French group in the field of specialty in vitro medical diagnostics, announces its financial communication calendar for the next year:

  • 2018 Turnover: January 29, 2019
  • 2018 Annual results: April 16, 2019
  • Annual Shareholders meeting: June 25, 2019
  • 2019 Half-year turnover: July 23, 2019
  • 2019 Half-year results: October 15, 2019

Calendar may be subject to change and is communicated on an indicative basis.

Upcoming financial meeting

2018 Turnover: January 29, 2019

About Eurobio Scientific

Eurobio Scientific (ex Diaxonhit) is a key player in the field of specialty in vitro diagnostics. It is involved from research to manufacturing and commercialization of diagnostic tests in the fields of transplantation, immunology and infectious diseases, and sells instruments and products for research laboratories, including biotechnology and pharmaceutical companies. Through many partnerships and a strong presence in hospitals, Eurobio Scientific has established its own distribution network and a portfolio of proprietary products in the molecular biology field. The Group has approximately 120 employees and two production units based in the Paris region and in the United States.


For more information, please visit: www.eurobio-scientific.com


The company is publicly listed on the Euronext Growth market in Paris

Euronext Growth BPI Innovation, PEA-PME 150 and Next Biotech indices.

Symbol : ALERS – ISIN Code: FR0013240934  –  Reuters : ALERS.PA  – Bloomberg : ALERS:FP




Eurobio Scientific Group

Denis Fortier, General Manager

Hervé Duchesne de Lamotte, General Manager

Tel. +33 1 69 79 64 80



Sophie Levesque / Mathieu Calleux

Investor Relations

Tel. +33 1 53 65 68 68 – eurobio-scientific@calyptus.net